ClinicalTrials.Veeva

Menu

Prospective Bladder Cancer Infrastructure (ProBCI)

P

Prospective Bladder Cancer Infrastructure Foundation

Status

Enrolling

Conditions

Bladder Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands

Enrollment

3,600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bladder cancer
  • Any stage except Ta
  • 18 years or older
  • Written informed consent

Exclusion criteria

  • No exclusion criteria

Note: participation in ProBCI does not exclude the patient from participation in other studies.

Trial design

3,600 participants in 1 patient group

Bladder cancer patients

Trial contacts and locations

23

Loading...

Central trial contact

A. Richters, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems